In the second part of a two part webinar series, we take the opportunity to interact with Nobel laureate Prof. Avram Hershko & Dr Miriam Kidron, CSO of Oramed Pharmaceuticals Inc. to discover, understand and unravel the journey of OralInsulin - from concept to a successful phase 3 candidate. Throughout history, oral administration has been regarded as the most convenient mode of drug delivery, as it requires minimal expertise and invasiveness. Although oral delivery works well for small-molecule drugs, oral delivery of macromolecules (particularly proteins and peptides) has been limited by acidic conditions in the stomach and low permeability across the intestinal epithelium. Oramed, is one one such company, that has made tremendous strides in the oral delivery of proteins and peptides, beginning with oral delivery of insulin (ORMD-0801) at Phase 3 entry in US.We hope that you enjoy the talks. Episode Credits: Hosts: Dr Prabuddha K. Kundu, Dr Nupur Mehrotra Concept & Direction: Ambar Mehrotra Moderator & Production: Malvika Khajuria Digital Marketing: Mohit Gupta Content Distribution: Dr Reshu Gupta, Dr Abyson Joseph, Dr Nikunj Harilal, Dr Sourav Sinha Roy & Puneet Jaju Session Support: Dr Ruchir Rastogi IT Support: Kapil Asija For more of such fascinating talks subscribe to our channel-
23 November 2020
